Black Diamond Therapeutics Inc Forecast, price target & analysts
Black Diamond Therapeutics Inc Target price 2025 - Analyst rating & recommendation
Black Diamond Therapeutics Inc Classifications & Recommendation:
Black Diamond Therapeutics Inc Price Target
| Target Price | $11.22 |
| Price | $2.54 |
| Potential |
341.73%
register free of charge
|
| Number of Estimates | 6 |
|
6 Analysts have issued a price target Black Diamond Therapeutics Inc 2026 .
The average Black Diamond Therapeutics Inc target price is $11.22.
This is
341.73%
register free of charge
$12.60
396.06%
register free of charge
$9.09
257.87%
register free of charge
|
|
| A rating was issued by 11 analysts: 10 Analysts recommend Black Diamond Therapeutics Inc to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Black Diamond Therapeutics Inc stock has an average upside potential 2026 of
341.73%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 0.00 | 71.40 |
6 Analysts have issued a sales forecast Black Diamond Therapeutics Inc 2025 . The average Black Diamond Therapeutics Inc sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an Black Diamond Therapeutics Inc EBITDA forecast 2025. The average Black Diamond Therapeutics Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Margin
6 Black Diamond Therapeutics Inc Analysts have issued a net profit forecast 2025. The average Black Diamond Therapeutics Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.27 | 0.25 |
| 32.45% | 119.69% | |
| P/E | 10.23 | |
| EV/Sales | 0.03 |
6 Analysts have issued a Black Diamond Therapeutics Inc forecast for earnings per share. The average Black Diamond Therapeutics Inc EPS is
This results in the following potential growth metrics and future valuations:
Black Diamond Therapeutics Inc...
Current Black Diamond Therapeutics Inc Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Aug 11 2025 |
| Raymond James |
Locked
➜
Locked
|
Locked | Jul 01 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 18 2025 |
| Stifel |
Locked
➜
Locked
|
Locked | Mar 07 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 06 2024 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Oct 09 2024 |
| Wedbush |
Locked
➜
Locked
|
Locked | Oct 08 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Aug 11 2025 |
|
Locked
Raymond James:
Locked
➜
Locked
|
Jul 01 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 18 2025 |
|
Locked
Stifel:
Locked
➜
Locked
|
Mar 07 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 06 2024 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Oct 09 2024 |
|
Locked
Wedbush:
Locked
➜
Locked
|
Oct 08 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
